F Cervantes Selected Research

F Cervantes Research Topics

Disease

8	Primary Myelofibrosis (Myelosclerosis) 01/2017 - 06/2000
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 09/2001
4	Splenomegaly 01/2017 - 06/2000
4	Neoplasms (Cancer) 10/2016 - 05/2000
4	Anemia 10/2011 - 06/2000
2	Disease Progression 01/2016 - 01/2000
2	Hemorrhage 06/2007 - 05/2001
2	Lymphoma (Lymphomas) 10/2004 - 01/2000
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2001 - 07/2000
1	Pruritus (Itching) 01/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Fever (Fevers) 01/2017
1	Venous Thromboembolism 10/2016
1	Cytopenia 10/2011
1	Splenosis 01/2010
1	Pleural Effusion (Pleural Effusions) 06/2008
1	Thrombosis (Thrombus) 06/2007
1	Essential Thrombocythemia 02/2007
1	Pain (Aches) 01/2004
1	Blast Crisis (Blast Phase) 09/2001
1	Portal Hypertension 05/2001
1	Second Primary Neoplasms (Neoplasms, Second) 03/2001
1	Residual Neoplasm 03/2001
1	Nervous System Diseases (Neurological Disorders) 07/2000
1	Paresis (Hemiparesis) 07/2000
1	Progressive Multifocal Leukoencephalopathy 07/2000
1	Lymphadenopathy 05/2000
1	Hodgkin Disease (Hodgkin's Disease) 05/2000
1	Hairy Cell Leukemia 01/2000
1	Thrombocytosis (Thrombocythemia) 01/2000

Drug/Important Bio-Agent (IBA)

5	ruxolitinibIBA 01/2017 - 02/2011
3	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 06/2008
2	Janus KinasesIBA 01/2016 - 02/2011
2	Janus Kinase InhibitorsIBA 01/2016 - 02/2011
2	Pharmaceutical PreparationsIBA 01/2015 - 02/2011
2	Prednisone (Sone)FDA LinkGeneric 03/2002 - 05/2000
1	Phosphotransferases (Kinase)IBA 01/2017
1	Vitamin K FDA Link 10/2016
1	Immunomodulating AgentsIBA 10/2011
1	Thalidomide (Thalomid)FDA Link 10/2011
1	Lenalidomide (CC 5013)FDA Link 10/2011
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 02/2011
1	fedratinibIBA 02/2011
1	CreatinineIBA 01/2010
1	Dasatinib (BMS 354825)FDA Link 06/2008
1	Janus Kinase 2IBA 06/2007
1	Dihydrotachysterol (AT 10)IBA 06/2007
1	Hydroxyurea (Hydrea)FDA LinkGeneric 02/2007
1	spleen fibrinolytic proteinase (human) (SFP)IBA 10/2004
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2004
1	Hemoglobins (Hemoglobin)IBA 10/2004
1	Analgesics (Analgesic Drugs)IBA 01/2004
1	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2001
1	InterferonsIBA 12/2001
1	Interferon-alpha (Interferon Alfa)IBA 12/2001
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 09/2001
1	Parathyroid Hormone (Parathormone)IBA 03/2001
1	Parathyroid Hormone-Related ProteinIBA 03/2001
1	fludarabineIBA 07/2000
1	Chlorambucil (Leukeran)FDA Link 07/2000
1	Danazol (Azol)FDA LinkGeneric 06/2000
1	Vinblastine (Vinblastine Sulfate)FDA Link 05/2000
1	Procarbazine (Matulane)FDA Link 05/2000
1	Mechlorethamine (Nitrogen Mustard)FDA Link 05/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2000
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2000
1	Vincristine (Oncovin)FDA LinkGeneric 05/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2000
1	Pentostatin (Nipent)FDA LinkGeneric 01/2000

Therapy/Procedure

10	Therapeutics 01/2017 - 01/2000
2	Stem Cell Transplantation 11/2015 - 03/2001
2	Splenectomy 10/2011 - 01/2010
2	Homologous Transplantation 03/2001 - 09/2000
2	Drug Therapy (Chemotherapy) 05/2000 - 01/2000
1	Duration of Therapy 10/2016
1	Radiotherapy 10/2011
1	Kidney Transplantation 01/2010
1	Transplantation 01/2010
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2001
1	Combination Drug Therapy (Combination Chemotherapy) 05/2000
1	COPP protocol 05/2000